Matches in SemOpenAlex for { <https://semopenalex.org/work/W2950615026> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2950615026 endingPage "S103" @default.
- W2950615026 startingPage "S103" @default.
- W2950615026 abstract "Background: The role of adjuvant treatment has been well established in cholangiocarcinoma, Gallbladder cancer (GC) is a rare and less studied tumor. Methods: We retrospectively analyzed all patients with gallbladder malignancy that underwent surgical removal of the gallbladder in our health system from 2007 to 2017. We compared clinical and oncological outcomes for two groups of patients: a group that received adjuvant treatment and a group that did not receive adjuvant treatment. The adjuvant treatment group was composed of patients who received either chemotherapy alone (19 patients) or chemo-radiation (21 patients). Results: Overall 69 patients with advanced (TNM stage III/IVa) gallbladder cancer (GBC) underwent resection for curative purposes. Among them, 40 patients (58%) were in the adjuvant treatment group and 29 patients (42%) were in the NO adjuvant treatment group. Gender (female, 58% vs 60%), ASA score (%) (I – 22 vs. 24, II - 39 vs. 37, III- 32 vs. 39, IV, 7 vs. 0), TNM stage IV (%, 17 vs. 10), and neoadjuvant chemotherapy administration (10% vs. 12%) were comparable (p = NS). The patients in theadjuvant treatment group were significantly younger (mean, years, 63 vs. 70, p = 0.03). Intraoperatively, surgical approach (laparoscopic, %, 28 vs. 25), incidental finding (%, 52 vs. 48), and tumor max dimension (mean, mm, 44 vs. 45) were all similar. Significantly more patients in the adjuvant treatment group underwent radical cholecystectomy (%, 69 vs. 98, p = 0.01). At median follow-up of 20 months, 43 patients recurred. Patients in adjuvant treatment group had significantly better survival (months, 25 vs. 10, p = 0.01). Similarly, the median disease-free survival was improved for patients in adjuvant treatment group (months, 18 vs. 8), although this didn’t reach statistical significance (p = 0.16). Conclusion: Adjuvant treatment has significant survival benefits for patients with advanced GBC and should be offered to patients with acceptable performance status. Despite these data, the application of adjuvant therapy after resection is not universally applied." @default.
- W2950615026 created "2019-06-27" @default.
- W2950615026 creator A5000389698 @default.
- W2950615026 creator A5009065201 @default.
- W2950615026 creator A5026123944 @default.
- W2950615026 creator A5031338272 @default.
- W2950615026 creator A5037695513 @default.
- W2950615026 creator A5040149265 @default.
- W2950615026 creator A5042734677 @default.
- W2950615026 creator A5043235329 @default.
- W2950615026 creator A5069694537 @default.
- W2950615026 creator A5080651605 @default.
- W2950615026 date "2019-03-01" @default.
- W2950615026 modified "2023-10-16" @default.
- W2950615026 title "The imortant role of adjuvant treatment in advanced gallblader cancer" @default.
- W2950615026 doi "https://doi.org/10.1016/j.hpb.2019.03.179" @default.
- W2950615026 hasPublicationYear "2019" @default.
- W2950615026 type Work @default.
- W2950615026 sameAs 2950615026 @default.
- W2950615026 citedByCount "0" @default.
- W2950615026 crossrefType "journal-article" @default.
- W2950615026 hasAuthorship W2950615026A5000389698 @default.
- W2950615026 hasAuthorship W2950615026A5009065201 @default.
- W2950615026 hasAuthorship W2950615026A5026123944 @default.
- W2950615026 hasAuthorship W2950615026A5031338272 @default.
- W2950615026 hasAuthorship W2950615026A5037695513 @default.
- W2950615026 hasAuthorship W2950615026A5040149265 @default.
- W2950615026 hasAuthorship W2950615026A5042734677 @default.
- W2950615026 hasAuthorship W2950615026A5043235329 @default.
- W2950615026 hasAuthorship W2950615026A5069694537 @default.
- W2950615026 hasAuthorship W2950615026A5080651605 @default.
- W2950615026 hasBestOaLocation W29506150261 @default.
- W2950615026 hasConcept C121608353 @default.
- W2950615026 hasConcept C126322002 @default.
- W2950615026 hasConcept C141071460 @default.
- W2950615026 hasConcept C146357865 @default.
- W2950615026 hasConcept C151730666 @default.
- W2950615026 hasConcept C2776534502 @default.
- W2950615026 hasConcept C2776694085 @default.
- W2950615026 hasConcept C2777148285 @default.
- W2950615026 hasConcept C2777863537 @default.
- W2950615026 hasConcept C2777982462 @default.
- W2950615026 hasConcept C2779399171 @default.
- W2950615026 hasConcept C3018227240 @default.
- W2950615026 hasConcept C530470458 @default.
- W2950615026 hasConcept C71924100 @default.
- W2950615026 hasConcept C86803240 @default.
- W2950615026 hasConcept C90924648 @default.
- W2950615026 hasConceptScore W2950615026C121608353 @default.
- W2950615026 hasConceptScore W2950615026C126322002 @default.
- W2950615026 hasConceptScore W2950615026C141071460 @default.
- W2950615026 hasConceptScore W2950615026C146357865 @default.
- W2950615026 hasConceptScore W2950615026C151730666 @default.
- W2950615026 hasConceptScore W2950615026C2776534502 @default.
- W2950615026 hasConceptScore W2950615026C2776694085 @default.
- W2950615026 hasConceptScore W2950615026C2777148285 @default.
- W2950615026 hasConceptScore W2950615026C2777863537 @default.
- W2950615026 hasConceptScore W2950615026C2777982462 @default.
- W2950615026 hasConceptScore W2950615026C2779399171 @default.
- W2950615026 hasConceptScore W2950615026C3018227240 @default.
- W2950615026 hasConceptScore W2950615026C530470458 @default.
- W2950615026 hasConceptScore W2950615026C71924100 @default.
- W2950615026 hasConceptScore W2950615026C86803240 @default.
- W2950615026 hasConceptScore W2950615026C90924648 @default.
- W2950615026 hasLocation W29506150261 @default.
- W2950615026 hasOpenAccess W2950615026 @default.
- W2950615026 hasPrimaryLocation W29506150261 @default.
- W2950615026 hasRelatedWork W167319750 @default.
- W2950615026 hasRelatedWork W169056058 @default.
- W2950615026 hasRelatedWork W2339627443 @default.
- W2950615026 hasRelatedWork W2389855711 @default.
- W2950615026 hasRelatedWork W2393478855 @default.
- W2950615026 hasRelatedWork W2401392746 @default.
- W2950615026 hasRelatedWork W2411814598 @default.
- W2950615026 hasRelatedWork W2444461917 @default.
- W2950615026 hasRelatedWork W2911897710 @default.
- W2950615026 hasRelatedWork W4312315088 @default.
- W2950615026 hasVolume "21" @default.
- W2950615026 isParatext "false" @default.
- W2950615026 isRetracted "false" @default.
- W2950615026 magId "2950615026" @default.
- W2950615026 workType "article" @default.